Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor

Strohkamp et al. Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor. Journal Oncologie 2021

Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study Protocol

Haentschel M et al. Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study Protocol. Diagnostics (Basel) 2020; Jul 6;10(7):459. doi: 10.3390/diagnostics10070459

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer

Latteyer S et al. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine 2016; Dec;54(3):733-741. doi: 10.1007/s12020-016-1080-9

Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing

Christopoulos P et al. Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing. Lung Cancer 2020; Oct;148:105-112. doi: 10.1016/j.lungcan.2020.08.007

to top icon